Neural network analysis as a novel skin outcome in a trial of belumosudil in patients with systemic sclerosis

Ilayda Gunes, Elana J. Bernstein, Shawn E. Cowper, Gauri Panse, Nikhil Pradhan, Lucy Duran Camacho, Norman Pagé, Elizabeth Bundschuh, Alyssa Williams, Mary Carns, Kathleen Aren, Sarah A. Fantus, Elizabeth R. Volkmann, Heather Bukiri, Chase Correia, Rui Wang, Vijaya B. Kolachalama, F. Perry Wilson, Seamus Mawe, J. Matthew Mahoney, Monique Hinchcliff

Abstract

Belumosudil was associated with a non-clinically meaningful improvement in mRSS. Fibrosis Score changes correlated with histologic feature changes (<i>e.g</i>., hyalinized collagen, SC fat loss) that were distinct from those associated with mRSS changes (<i>e.g</i>., telangiectasia, perivascular CD3+, and % of CD8 + among CD3+). These data suggest that AI applied to SSc biopsies may be useful for quantifying pathologic features of SSc beyond skin thickness.
BibTeX
@inproceedings{gunes2025neural,
  author = {Ilayda Gunes and Elana J. Bernstein and Shawn E. Cowper and Gauri Panse and Nikhil Pradhan and Lucy Duran Camacho and Norman Pagé and Elizabeth Bundschuh and Alyssa Williams and Mary Carns and Kathleen Aren and Sarah A. Fantus and Elizabeth R. Volkmann and Heather Bukiri and Chase Correia and Rui Wang and Vijaya B. Kolachalama and F. Perry Wilson and Seamus Mawe and J. Matthew Mahoney and Monique Hinchcliff},
  title = {{Neural network analysis as a novel skin outcome in a trial of belumosudil in patients with systemic sclerosis}},
  booktitle = {Arthritis},
  year = {2025},
  doi = {10.1186/s13075-025-03508-9},
}

Loading related content...

Figure